Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market, Global Outlook and Forecast 2022-2028

March 2022 | 65 pages | ID: T1B849ACD3B7EN
Market Monitor Global

Abstracts

Novel Technologies for Delivery of Proteins, Antibodies and Nucleic Acids

This report contains market size and forecasts of Technologies for Delivery of Proteins, Antibodies and Nucleic Acids in Global, including the following market information:

Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

HEPtune® Technology Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Technologies for Delivery of Proteins, Antibodies and Nucleic Acids include Aphios, Arbutus Biopharma, Camurus, ConjuChem, InnoCore Pharmaceuticals and LATITUDE Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Technologies for Delivery of Proteins, Antibodies and Nucleic Acids companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Segment Percentages, by Type, 2021 (%)

• HEPtune® Technology
• Intravail® Technology
• RapidMist™
• TheraKine Technology
• Arestat™ Technology
• DelSiTech™ Silica Matrix
• ImSus® Technology
• PLEX™ Technology
• ENHANZE® Technology

Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Segment Percentages, by Application, 2021 (%)

• Delivery of Protein
• Delivery of Nucleic Acids
• Delivery Antibody

Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Technologies for Delivery of Proteins, Antibodies and Nucleic Acids revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Technologies for Delivery of Proteins, Antibodies and Nucleic Acids revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Aphios
• Arbutus Biopharma
• Camurus
• ConjuChem
• InnoCore Pharmaceuticals
• LATITUDE Pharmaceuticals

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL TECHNOLOGIES FOR DELIVERY OF PROTEINS, ANTIBODIES AND NUCLEIC ACIDS OVERALL MARKET SIZE

2.1 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size: 2021 VS 2028
2.2 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Players in Global Market
3.2 Top Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Companies Ranked by Revenue
3.3 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue by Companies
3.4 Top 3 and Top 5 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Companies in Global Market, by Revenue in 2021
3.5 Global Companies Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product Type
3.6 Tier 1, Tier 2 and Tier 3 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Players in Global Market
  3.6.1 List of Global Tier 1 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Companies
  3.6.2 List of Global Tier 2 and Tier 3 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size Markets, 2021 & 2028
  4.1.2 HEPtune® Technology
  4.1.3 Intravail® Technology
  4.1.4 RapidMist™
  4.1.5 TheraKine Technology
  4.1.6 Arestat™ Technology
  4.1.7 DelSiTech™ Silica Matrix
  4.1.8 ImSus® Technology
  4.1.9 PLEX™ Technology
  4.1.10 ENHANZE® Technology
4.2 By Type - Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue & Forecasts
  4.2.1 By Type - Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, 2017-2022
  4.2.2 By Type - Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, 2023-2028
  4.2.3 By Type - Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, 2021 & 2028
  5.1.2 Delivery of Protein
  5.1.3 Delivery of Nucleic Acids
  5.1.4 Delivery Antibody
5.2 By Application - Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue & Forecasts
  5.2.1 By Application - Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, 2017-2022
  5.2.2 By Application - Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, 2023-2028
  5.2.3 By Application - Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, 2021 & 2028
6.2 By Region - Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue & Forecasts
  6.2.1 By Region - Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, 2017-2022
  6.2.2 By Region - Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, 2023-2028
  6.2.3 By Region - Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, 2017-2028
  6.3.2 US Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, 2017-2028
  6.3.3 Canada Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, 2017-2028
  6.3.4 Mexico Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, 2017-2028
  6.4.2 Germany Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, 2017-2028
  6.4.3 France Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, 2017-2028
  6.4.4 U.K. Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, 2017-2028
  6.4.5 Italy Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, 2017-2028
  6.4.6 Russia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, 2017-2028
  6.4.7 Nordic Countries Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, 2017-2028
  6.4.8 Benelux Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, 2017-2028
  6.5.2 China Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, 2017-2028
  6.5.3 Japan Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, 2017-2028
  6.5.4 South Korea Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, 2017-2028
  6.5.5 Southeast Asia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, 2017-2028
  6.5.6 India Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, 2017-2028
  6.6.2 Brazil Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, 2017-2028
  6.6.3 Argentina Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, 2017-2028
  6.7.2 Turkey Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, 2017-2028
  6.7.3 Israel Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, 2017-2028
  6.7.4 Saudi Arabia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, 2017-2028
  6.7.5 UAE Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Aphios
  7.1.1 Aphios Corporate Summary
  7.1.2 Aphios Business Overview
  7.1.3 Aphios Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Major Product Offerings
  7.1.4 Aphios Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue in Global Market (2017-2022)
  7.1.5 Aphios Key News
7.2 Arbutus Biopharma
  7.2.1 Arbutus Biopharma Corporate Summary
  7.2.2 Arbutus Biopharma Business Overview
  7.2.3 Arbutus Biopharma Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Major Product Offerings
  7.2.4 Arbutus Biopharma Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue in Global Market (2017-2022)
  7.2.5 Arbutus Biopharma Key News
7.3 Camurus
  7.3.1 Camurus Corporate Summary
  7.3.2 Camurus Business Overview
  7.3.3 Camurus Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Major Product Offerings
  7.3.4 Camurus Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue in Global Market (2017-2022)
  7.3.5 Camurus Key News
7.4 ConjuChem
  7.4.1 ConjuChem Corporate Summary
  7.4.2 ConjuChem Business Overview
  7.4.3 ConjuChem Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Major Product Offerings
  7.4.4 ConjuChem Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue in Global Market (2017-2022)
  7.4.5 ConjuChem Key News
7.5 InnoCore Pharmaceuticals
  7.5.1 InnoCore Pharmaceuticals Corporate Summary
  7.5.2 InnoCore Pharmaceuticals Business Overview
  7.5.3 InnoCore Pharmaceuticals Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Major Product Offerings
  7.5.4 InnoCore Pharmaceuticals Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue in Global Market (2017-2022)
  7.5.5 InnoCore Pharmaceuticals Key News
7.6 LATITUDE Pharmaceuticals
  7.6.1 LATITUDE Pharmaceuticals Corporate Summary
  7.6.2 LATITUDE Pharmaceuticals Business Overview
  7.6.3 LATITUDE Pharmaceuticals Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Major Product Offerings
  7.6.4 LATITUDE Pharmaceuticals Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue in Global Market (2017-2022)
  7.6.5 LATITUDE Pharmaceuticals Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Opportunities & Trends in Global Market
Table 2. Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Drivers in Global Market
Table 3. Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Restraints in Global Market
Table 4. Key Players of Technologies for Delivery of Proteins, Antibodies and Nucleic Acids in Global Market
Table 5. Top Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Share by Companies, 2017-2022
Table 8. Global Companies Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product Type
Table 9. List of Global Tier 1 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2023-2028
Table 30. Aphios Corporate Summary
Table 31. Aphios Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product Offerings
Table 32. Aphios Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue (US$, Mn), (2017-2022)
Table 33. Arbutus Biopharma Corporate Summary
Table 34. Arbutus Biopharma Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product Offerings
Table 35. Arbutus Biopharma Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue (US$, Mn), (2017-2022)
Table 36. Camurus Corporate Summary
Table 37. Camurus Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product Offerings
Table 38. Camurus Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue (US$, Mn), (2017-2022)
Table 39. ConjuChem Corporate Summary
Table 40. ConjuChem Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product Offerings
Table 41. ConjuChem Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue (US$, Mn), (2017-2022)
Table 42. InnoCore Pharmaceuticals Corporate Summary
Table 43. InnoCore Pharmaceuticals Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product Offerings
Table 44. InnoCore Pharmaceuticals Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue (US$, Mn), (2017-2022)
Table 45. LATITUDE Pharmaceuticals Corporate Summary
Table 46. LATITUDE Pharmaceuticals Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product Offerings
Table 47. LATITUDE Pharmaceuticals Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Segment by Type in 2021
Figure 2. Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Segment by Application in 2021
Figure 3. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue in 2021
Figure 8. By Type - Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share, 2017-2028
Figure 9. By Application - Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share, 2017-2028
Figure 10. By Region - Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share, 2017-2028
Figure 11. By Country - North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share, 2017-2028
Figure 12. US Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share, 2017-2028
Figure 16. Germany Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2017-2028
Figure 17. France Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share, 2017-2028
Figure 24. China Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2017-2028
Figure 28. India Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share, 2017-2028
Figure 30. Brazil Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share, 2017-2028
Figure 33. Turkey Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2017-2028
Figure 37. Aphios Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Arbutus Biopharma Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Camurus Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. ConjuChem Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. InnoCore Pharmaceuticals Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. LATITUDE Pharmaceuticals Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Year Over Year Growth (US$, Mn) & (2017-2022)